Qube Research & Technologies (QRT)’s Atlanta Braves Holdings Series B BATRK Stock Holding History
Bought
Maintained
Sold
Other funds holding BATRK
BBCM
HRCM
SSP
GF
GI
Qube Research & Technologies (QRT)'s BATRK Position: Q2 2026 in Review
Qube Research & Technologies (QRT) reduced its Atlanta Braves Holdings Series B (BATRK) stake by 53% in Q2 2026, selling an estimated $10.7M and leaving 192,240 shares worth $9.98M. The position accounts for 0.01% of the portfolio, ranked #1287.
Qube Research & Technologies (QRT) first reported a position in BATRK in Q4 2019 and has held it in 22 quarters since. The position peaked at $19.9M in Q4 2025. 325 funds tracked by Wall St. Rank hold BATRK as of Q2 2026.
- Qube Research & Technologies (QRT) held 192,240 shares of Atlanta Braves Holdings Series B worth $9.98M as of Q2 2026.
- Qube Research & Technologies (QRT) sold 217,869 Atlanta Braves Holdings Series B shares in Q2 2026, an estimated $10.7M.
- Atlanta Braves Holdings Series B made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1287 holding.
- Qube Research & Technologies (QRT) first reported a position in Atlanta Braves Holdings Series B in Q4 2019 and has held it in 22 quarters since.
- Qube Research & Technologies (QRT)'s Atlanta Braves Holdings Series B position peaked at $19.9M in Q4 2025.
- 325 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series B as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.